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A ‘‘switch’’ from oxidative phosphorylation
(OXPHOS) to aerobic glycolysis is a hallmark of
T cell activation and is thought to be required to
meet the metabolic demands of proliferation. How-
ever, why proliferating cells adopt this less efficient
metabolism, especially in an oxygen-replete environ-
ment, remains incompletely understood. We show
here that aerobic glycolysis is specifically required
for effector function in T cells but that this pathway
is not necessary for proliferation or survival. When
activated T cells are provided with costimulation
and growth factors but are blocked from engaging
glycolysis, their ability to produce IFN-g is markedly
compromised. This defect is translational and is
regulated by the binding of the glycolysis enzyme
GAPDH to AU-rich elements within the 30 UTR of
IFN-g mRNA. GAPDH, by engaging/disengaging
glycolysis and through fluctuations in its expression,
controls effector cytokine production. Thus, aerobic
glycolysis is a metabolically regulated signaling
mechanism needed to control cellular function.
INTRODUCTION
Nonproliferating cells metabolize glucose to pyruvate, which
enters the mitochondrial tricarboxylic acid (TCA) cycle and gen-
erates reducing equivalents for fueling ATP production via oxida-
tive phosphorylation (OXPHOS). However, proliferating cells
such as activated T cells and cancer cells engage glycolysis,
where pyruvate is fermented to lactate in the cytoplasm even
when sufficient oxygen is present to utilize OXPHOS, a process
termed the Warburg effect (Fox et al., 2005; Frauwirth et al.,
2002; Gerriets and Rathmell, 2012; Jones and Thompson,
2007). Although both processes generate ATP, glycolysis isless efficient, indicating that it might provide other advantages
during proliferation. It is thought that the metabolism of prolifer-
ating cells is adapted to facilitate uptake and incorporation of
nutrients into the biomass needed to produce a daughter cell;
i.e., aerobic glycolysis is necessary, both in terms of energy
and biosynthesis, for cellular proliferation (Lunt and Vander
Heiden, 2011; Vander Heiden et al., 2009). However, cells such
as dendritic cells switch from OXPHOS to aerobic glycolysis
upon TLR-induced activation but do not proliferate (Krawczyk
et al., 2010). This observation suggests that aerobic glycolysis
may be necessary for pathways other than, or in addition to,
those underlying proliferation. Therefore, we sought to unravel
the requirements for OXPHOS and aerobic glycolysis in T cell
activation, proliferation, and effector function.
RESULTS
OXPHOS, but Not Aerobic Glycolysis, Is Required for the
Activation of Naive T Cells
We measured the extracellular acidification rate (ECAR), an
indicator of aerobic glycolysis, and the oxygen consumption
rate (OCR), an indicator of OXPHOS, of in-vitro- and in-vivo-
activated T cells and found that both had high ECAR and
OCR in comparison to naive cells (Figure 1A), indicating that
activated T cells use both aerobic glycolysis and OXPHOS
(Gatza et al., 2011; Michalek et al., 2011; van der Windt and
Pearce, 2012; Wang et al., 2011). To assess whether mitochon-
drial ATP derived from OXPHOS was necessary for T cell acti-
vation, we activated CFSE-labeled naive T cells in the presence
of the ATP synthase inhibitor oligomycin and measured subse-
quent proliferation. Even low concentrations of oligomycin
(4.1 nM) inhibited proliferation (Figure 1B) and activation marker
expression (Figure 1C). We verified that the concentrations of
oligomycin inhibiting activation and proliferation also reduced
OCR (Figure 1D) and ATP (Figure S1A available online). These
data indicate that T cell activation requires mitochondrial
ATP. It is also worth considering that, in addition to inhibiting
ATP production directly, it is possible that blocking electronCell 153, 1239–1251, June 6, 2013 ª2013 Elsevier Inc. 1239
Figure 1. OXPHOS, but Not Aerobic Glycolysis, Is Required for the Activation of T Cells
(A) OCR and ECAR of naive and activated T cells were assessed. Activated CD4+ T cells were obtained from L. monocytogenes-infected mice or after in vitro
stimulation with anti-CD3/28 for 72 hr. OCR/ECAR ratio of the cells was also determined; *p = 0.014 and **p < 0.0001.
(B) CFSE-labeled naive T cells were activated with anti-CD3/28 in the presence or absence of oligomycin (Oligo) for indicated times, and then proliferation was
measured by CFSE dilution.
(C) Naive T cells were activated with anti-CD3/28 for 72 hr in the absence (no drug) or in the presence of oligomycin. The mean fluorescence intensity (MFI) of the
activation markers CD44 and CD25 were determined and normalized to the level expressed in naive cells; *p = 0.001 for CD44, *p = 0.002 for CD25.
(D) OCR of T cells that were activated with anti-CD3/28 and cultured in the presence of low concentrations of oligomycin for 3 days, *p = 0.0001.
(E) CFSE-labeled naive T cells were activated with anti-CD3/28 and cultured in medium supplemented either with (+Glc) or without (Glc) glucose or with
galactose (+Gal),or galactose plus oligomycin (+Gal/Oligo) for 6 days. CFSE dilution was measured 1, 3, or 6 days after activation.
(F) Live-cell (7AAD-) numbers of T cells were determined and normalized to the number of live cells cultured in glucose medium at the indicated times.
(G) OCR and ECAR of T cells that were activated for 3 days with anti-CD3/28 and cultured inmedium supplemented either with glucose (+Glc) or galactose (+Gal),
*p = 0.0001.
Data are representative of at least two independent experiments and depict mean ± SEM (error bars) of quadruplicates (A), (C), (D), (F), and (G) or of three
independent experiments (B) and (E). See also Figure S1.transport chain (ETC) flux in naive T cells with oligomycin will
lead to radical oxygen species (ROS) accumulation, thereby
inducing cellular stress and contributing to the subsequent
drop in ATP production.
Glucose is the normal sugar in T cell media and, when acti-
vated in glucose, T cells adopt aerobic glycolysis (Frauwirth
et al., 2002; Gerriets and Rathmell, 2012). Previous studies
demonstrated that T cells culturedwithout sugar have severe de-
fects (Cham et al., 2008; Cham and Gajewski, 2005; Tripmacher
et al., 2008). To specifically address the role of aerobic glycolysis
in T cell activation, we activated naive T cells in either glucose or
galactose. Cells grown in galactose are forced to respire and do1240 Cell 153, 1239–1251, June 6, 2013 ª2013 Elsevier Inc.not use aerobic glycolysis (Bustamente et al., 1977; Le Goffe
et al., 1999; Rossignol et al., 2004; Weinberg et al., 2010). We
found that T cells cultured in galactose activated (Figure S1B),
generated ATP (Figure S1C), proliferated—albeit at a slower
initial rate than cells grown in glucose (Figure 1E)—and survived
(Figure 1F). Cells grown without sugars did not proliferate (Fig-
ure 1E), and their survival decreased precipitously (Figure 1F).
Importantly, cells grown in galactose with oligomycin neither
proliferated (Figure 1E) nor survived (Figure 1F), confirming that
T cells activated in galactose fuel proliferation and survival with
mitochondrial ATP from OXPHOS (Figure 1G; OCR) and not by
aerobic glycolysis (Figure 1G; ECAR).
Figure 2. Activated T Cells Can Use Aerobic Glycolysis or OXPHOS Interchangeably to Fuel Proliferation and Survival
(A) Naive T cells were activatedwith anti-CD3/28 for 1, 2, or 3 days andwere CFSE labeled and cultured with or without oligomycin. Proliferation wasmeasured by
CFSE dilution at 24 and 72 hr post-CFSE labeling.
(B) Naive T cells were activated with anti-CD3/28 for 3 days. Cells were then CFSE labeled and cultured with mitochondrial inhibitors. Proliferation wasmeasured
by CFSE dilution at 24, 48, and 72 hr post-CFSE labeling (left), and OCR and ECAR were measured at 72 hr after culturing with or without mitochondrial inhibitors
(O, oligomycin; R/A, rotenone and antimycin-A) (right).
(C) Naive T cells were activatedwith anti-CD3/28 in glucosemedium for 3 days, followed byCFSE labeling. The CFSE-labeled activated cells were then cultured in
medium supplemented either with glucose (+Glc), glucose plus 1 mM oligomycin (Glc+Oligo), without glucose Glc), or with galactose (+Gal), or galactose
plus 4 nM oligomycin (Gal+Oligo). CFSE dilution was measured at 24 and 72 hr post-CFSE labeling.
(D) Live-cell (7-AAD) numbers of activated CD4+ T cells were determined at 72 hr and normalized to the number of live cells cultured in glucose medium at 0 hr.
(E and F) T cells were activated with anti-CD3/28 in glucose medium for 3 days. OCR and ECAR were measured 1 hr after these cells were switched into media
with glucose (+Glc) or without glucose (Glc) or with galactose (+Gal).
Data are representative of at least three independent experiments (A), (B, left), and (C) or of two independent experiments and depict mean ± SEM (error bars) of
quadruplicates (B, right), (D), (E), and (F); *p = 0.0001. See also Figures S1 and S2.Activated T Cells Can Use Either Aerobic Glycolysis or
OXPHOS to Fuel Proliferation
To determine whether OXPHOS was required for continued
proliferation of blasting T cells, we activated naive T cells and
added oligomycin 1, 2, or 3 days later. We then assessed
continued proliferation 24 and 72 hr following the addition of
drug (Figure 2A). By 2 days postactivation, cells were able to
proliferate in high concentrations of oligomycin (100 nm—
1 mm) (Figure 2A). This was not the case 1 day postactivation,
indicating that T cells do not relinquish the need to generate
energy from their mitochondria until between 1 and 2 days
postactivation (Figure 2A). To confirm this result and to test
whether ETC activity was required for proliferation, we cultured
activated T cells in the presence of rotenone and antimycin A,
complex I and III inhibitors, respectively, and found that neither
abrogated proliferation of activated T cells (Figure 2B, left). Wedid find, however, that myxothiazol, a complex III inhibitor that
blocks ROS production from this site, inhibited T cell division
(data not shown), agreeing with published observations that
ROS can act as a positive signal for cell proliferation (Weinberg
et al., 2010). Importantly, addition of oligomycin or antimycin A
and rotenone decreased OCR while augmenting ECAR (Fig-
ure 2B, right), showing that cells offset ETC inhibition
by enhancing aerobic glycolysis and that, over time, cells
compensate for the initial drop in ATP caused by oligomycin
(Figure S1D). Our metabolite analysis showed increased
a-ketoglutarate in T cells cultured with mitochondrial inhibitors
(Figure S2A). Although these data do not prove that glutamine
is the anaplerotic substrate that replenishes the TCA cycle
in this setting, they might be consistent with increased
glutamine-dependent metabolism (Wang et al., 2011). Recently
published papers show that cells unable to engage in oxidativeCell 153, 1239–1251, June 6, 2013 ª2013 Elsevier Inc. 1241
metabolism due to mutations in the ETC or TCA cycle, hypoxia,
or culture with mitochondrial inhibitors use reductive carboxyl-
ation of a-ketoglutarate to produce citrate and other precursors
during growth and proliferation (Metallo et al., 2012; Mullen
et al., 2012). We might speculate that glutamine-dependent
reductive carboxylation, rather than oxidative metabolism,
also fuels the TCA cycle and supports precursor biosynthesis
for the proliferation of T cells cultured with ETC inhibitors in
our system.
To determine whether aerobic glycolysis is required for
continued proliferation of activated T cells, we activated
T cells for 3 days in glucose, and then we either continued cul-
ture in glucose or switched cells to galactose. We found that
activated T cells proliferated (Figure 2C), survived (Figure 2D),
retained activation markers (Figure S1E), and generated ATP
(Figure S1F), whether utilizing aerobic glycolysis or OXPHOS.
In contrast to T cells growing on glucose, when oligomycin
was added to activated T cells forced to grow on galactose,
the cells ceased proliferating (Figure 2C), and survival
decreased precipitously (Figure 2D), indicating that these cells
use OXPHOS (Figure 2E) and not aerobic glycolysis (Figure 2F)
to fuel metabolic demands. Unlike T cells cultured in 13C-
glucose, cells cultured in 13C-galactose produce low levels of
lactate and pyruvate when compared to glucose-cultured cells
(Figure S2B), and these cells incorporate low levels of galactose
carbon into what are already reduced levels of pyruvate (Fig-
ure S2C), lactate, or into TCA cycle intermediates (Figure S2D).
Consistent with previously published observations in other cell
types (Bustamente et al., 1977; Gohil et al., 2010; Le Goffe
et al., 1999; Rossignol et al., 2004; Weinberg et al., 2010), these
results indicate that galactose is not as efficiently metabolized
as glucose in the glycolysis pathway—or into the TCA cycle—
in T cells. We also found that galactose-cultured T cells had
higher levels of glutamine and glutamate (Figure S2B). Although
these results do not prove whether these cells are using gluta-
mine as an alternate substrate for OXPHOS in this setting,
they might suggest this possibility and, if so, would be consis-
tent with previous observations showing that glutamine is the
major energy source for cells cultured in galactose (Reitzer
et al., 1979). Together, these data show that activated T cells
can use OXPHOS or aerobic glycolysis to support proliferation
and survival.
Aerobic Glycolysis Is Required for Optimal IFN-g
Cytokine Production in T Cells
We have shown here that T cell activation and proliferation can
proceed in the absence of aerobic glycolysis and can be fully
supported by OXPHOS. Nevertheless, the observation that acti-
vated T cells engage aerobic glycolysis remains (Figure 1A).
Therefore, we ask the question: what function does aerobic
glycolysis serve in activated T cells? Because activated T cells
assume effector functions, such as the production of adaptive
cytokines, in addition to enhanced proliferation, we measured
cytokine production in activated T cells cultured in either glucose
or galactose. We found that T cells cultured in galactose had a
severe defect in IFN-g and IL-2 production (Figures 3A, 3B,
S3A, and S3B). Neither mitochondrial ATP nor ETC function
was required for cytokine production, as levels were unaffected1242 Cell 153, 1239–1251, June 6, 2013 ª2013 Elsevier Inc.in cells cultured with mitochondrial inhibitors (Figures 3C and
S3A), indicating that aerobic glycolysis—and not OXPHOS—is
a critical metabolic pathway for effector function. Neither the
expression of IFN-g or IL-2 messenger RNA (mRNA), nor protein
expression of the transcription factor T-bet, differed between
glucose- and galactose-cultured cells, suggesting that defective
cytokine production was due to a block in translation rather than
transcription (Figure 3D and data not shown). To rule out any
possibility that the lower amount of IL-2 produced by galac-
tose-cultured T cells was responsible for their lower IFN-g
cytokine expression, all T cells were cultured in the presence
of 10 U/ml of exogenous IL-2.
We reasoned that altered cytokine translation could reflect a
cellular stress response (Scheu et al., 2006) caused by the sub-
strate transition from glucose to galactose. To explore this pos-
sibility, we assessed mTOR target activation and AMPK-a and
eIF2-a phosphorylation in cells cultured in glucose versus galac-
tose and found no differences in these pathways (Figure 3E). We
also measured the mRNA expression of the integrated stress
response genes Hspa5 and Ppp1r15a in glucose- and galac-
tose-cultured cells with or without thapsigargin, which induces
ER stress (Scheu et al., 2006). We found that glucose- and
galactose-cultured cells expressed BiP or GADD34 to similar
levels and not to the high levels expressed when ER stress
is induced (Figure 3F). Together, these data indicate that the
induction of a classical stress response is not responsible for
the block in translation of effector cytokine mRNAs in galac-
tose-cultured T cells. We also found that cell size (Figure 3G),
total protein levels (Figure 3H), IFN-g protein stability (Fig-
ure S3C), and ROS production (Figure S3D) were similar
between T cells cultured in glucose and galactose, suggesting
that the decrease in cytokine production was not due to broad
differences in cellular health. Together, these data demonstrate
that the engagement of aerobic glycolysis constitutes a physio-
logical mechanism unrelated to ER stress that controls cytokine
mRNA translation.
Aerobic Glycolysis Controls the Preferential Translation
of IFN-g mRNA
To establish whether the engagement of aerobic glycolysis pref-
erentially regulates the translation of cytokine mRNAs, we frac-
tionated ribosomes from glucose- and galactose-cultured cells
and measured IFN-g and b-actin transcripts. We found that
IFN-g transcripts were mainly associated with polysomes in
activated T cells using aerobic glycolysis, indicating ongoing
translation of IFN-g mRNA, whereas more IFN-g transcripts
were associated with monosomes in galactose-cultured acti-
vated T cells, indicating less translation of IFN-g mRNA in cells
using OXPHOS (Figure 4A). Importantly, b-actin mRNAs, which
are highly translated and associated with a greater number of
polysomes than are IFN-g transcripts (peaks shift to the right),
were equally associated with polysomes in both conditions (Fig-
ure 4A). This is consistent with normal expression of b-actin pro-
tein regardless of the sugar substrate utilized. These results
show that the engagement of aerobic glycolysis specifically per-
mits the translation of IFN-g mRNA in activated T cells and
thereby regulates the ability of the cells to attain full effector
status.
Figure 3. Aerobic Glycolysis Is Required for Optimal IFN-g Cytokine Production in T Cells
(A) Intracellular IFN-gwasmeasured in T cells that were activated with anti-CD3/28 inmedium containing either glucose (Glc) or galactose (Gal) for 4 days (top), or
for 3 to 4 days in Glc followed by culture in Glc or Gal for 1 day (bottom, (B)–(H); or with oligomycin or rotenone/antimycin A for additional one day (C).
(B) IFN-g in the culture supernatant was measured by ELISA after restimulation. Frequencies of IFN-g-producing cells are shown (A) and (C).
(D) IFN-g mRNA and T-bet expression.
(E) Western blot analysis of p-4EBP1 and p-S6K and p-AMPK and p-eIF2-a were examined.
(F) Hspa5 and Ppp1r15a expression after treatment with 0.1 mM thapsigargin (Thaps) for 4 hr.
(G) Mean cell diameter and volume as measured by laser light-scattering method.
(H) Total protein density (left) and total protein concentration (right) measured by Sypro Ruby staining and BCA assay, respectively.
Plots in (A) and (C) are representative of >3 independent experiments; (B) graph shows themean ±SEM (*p = 0.001) from two independent experiments; (D) qPCR
data are generated from five independent experiments and are shown as mean ± SEM, n.s., not significant, and the FACS plot is representative of two inde-
pendent experiments; (E) blots are representative of two to four independent experiments; (F) results are presented as mean ± SEM from six independent
experiments for cells without Thaps treatment and from one experiment for cells with Thaps treatment; (G) data are representative of two independent exper-
iments; and (H) data are presented as mean ± SEM from three independent experiments. See also Figure S3.The Defect in IFN-g Translation Evident in the Absence
of Aerobic Glycolysis Is Marked by Enhanced GAPDH
Binding to IFN-g mRNA
We next investigated how engaging aerobic glycolysis could
specifically alter IFN-gmRNA translation. Given that cells grown
on galactose do not engage aerobic glycolysis (Figures 1G and
2F)—nor do they robustly metabolize galactose into the glycol-
ysis pathway (Figure S2)—we hypothesized that, when cells are
grown in galactose, their glycolysis enzymes are not engaged to
the same extent as they are in cells grown in glucose and there-
fore become available to perform other functions. Besides its
metabolic function, the glycolysis enzyme GAPDH has several
additional roles, including acting as a mRNA-binding protein
(Singh and Green, 1993) that regulates mRNA translation
(Bonafe´ et al., 2005; Kondo et al., 2011; Nagy et al., 2000;
Rodrı´guez-Pascual et al., 2008; Zhou et al., 2008). Specifically,GAPDH has been shown to bind to adenylate-uridylate (AU)-
rich elements in the 30 UTRs of IFN-g and IL-2 mRNAs (Nagy
and Rigby, 1995). Furthermore, it is well established that 30
UTR-dependent mechanisms limit the translation of cytokine
mRNA (Anderson, 2010; Garcia-Sanz and Lenig, 1996; Villarino
et al., 2011). To investigate whether aerobic glycolysis regulates
the ability of GAPDH protein to bind cytokine mRNA, we immu-
noprecipitated GAPDH from activated T cells cultured in
glucose or galactose and assessed its association with IFN-g
transcripts. We found a >10-fold increase in GAPDH-associ-
ated IFN-g transcripts in cells cultured in galactose as com-
pared to those cultured in glucose (Figure 4B). This enhanced
binding of GAPDH to IFN-g mRNA in galactose-cultured cells
correlated with their defect in IFN-g production (Figures 3A,
3B, S3A, and S3B). Similar binding of GAPDH mRNA to GAPDH
protein was observed between both cell types, indicating thatCell 153, 1239–1251, June 6, 2013 ª2013 Elsevier Inc. 1243
Figure 4. The Translational Defect in Cytokine Production Evident in the Absence of Aerobic Glycolysis Is Marked by Enhanced GAPDH
Binding to IFN-g mRNA
(A) Polysome analysis of T cells that were activated with anti-CD3/28 for 3 days in media containing glucose and then differentially cultured in media with either
glucose (Glc) or galactose (Gal) for an additional day. The 40, 60, and 80S ribosomal subunits and polysomes were fractionated and monitored with continuous
A254 measurements. A representative polysome profile of cells in Glc (red) and in Gal (blue) is shown in the upper panel. Total RNA was extracted from each
fraction, and IFN-g (middle) and b-actin (bottom) expression was measured by qPCR and calculated as a percentage of total RNA collected in all fractions. The
proportion of each mRNA between nontranslated (1–7) and translated (8–14) fractions is plotted. Data are representative results from two independent
experiments.
(B) GAPDH-specific antibodies were used to immunoprecipitate GAPDH from extracts of activated T cells differentially cultured in media with either Glc or Gal.
BoundGAPDH and associatedmRNAwere analyzed bywestern blot (top) and qRT-PCR (bottom). Total input per immunoprecipitation is shown (top). Data show
results from six independent experiments as mean ± SEM (error bar) and are normalized to Glc cells (*p = 0.025).
(C) IFN-g mRNA transcripts and housekeeping gene transcripts (GAPDH mRNA) that bind to GAPDH protein in cells cultured in galactose (Gal) versus cells
cultured in glucose (Glc). Relative levels were calculated by subtracting background binding (no primary antibody control) from primary antibody-specific binding
and then normalizing to transcripts levels bound to GAPDH in Glc cells.
Mean ± SEM (error bar) of three independent experiments. See also Figure S4.GAPDH protein preferentially binds IFN-g transcripts—rather
than housekeeping gene transcripts—only in cells cultured in
galactose (Figure 4C). We also found that IL-2 mRNA was asso-
ciated with GAPDH to a greater extent when cells were cultured
in galactose rather than in glucose (Figure S4). Together, these
results suggest that the engagement of aerobic glycolysis
permits effector cytokine production by preventing GAPDH
from binding to and inhibiting the translation of cytokine
transcripts.
A 30 UTR-Dependent Mechanism Limits IFN-g
Expression in Galactose-Cultured CD4 T Cells
It has been previously shown that 30 UTR-dependent mecha-
nisms limit the translation of cytokine mRNA (Villarino et al.,
2011). We sought to establish whether a 30 UTR-dependent
mechanism limited the production of IFN-g in CD4 T cells
cultured in galactose. To accomplish this, we used a series of
previously reported UTR sensors, where the IFN-g 30 UTR or a1244 Cell 153, 1239–1251, June 6, 2013 ª2013 Elsevier Inc.control 30 UTR were fused to green fluorescent protein (GFP) in
a retroviral vector, thus allowing for protein expression to be
measured by GFP fluorescence (Villarino et al., 2011). We found
that, in CD4 T cells transduced with a mutant in which specific
residues of the AU-rich elements were mutated (ARE*), GFP
expression was greatly increased over that of cells transduced
with the full-length IFN-g 30 UTR construct (Figure 5A), showing
that translation of mRNA is limited by the AU-rich region of the
IFN-g 30 UTR. We also transduced cells with two other IFN-g 30
UTR mutants—one that lacks the AU-rich region and one that
contains the AU-region but is truncated in a different region of
the promoter—and found that they either enhance or limit GFP
expression, respectively. As a control, we transduced cells
with a construct containing the GAPDH 30 UTR fused to GFP.
As expected, the GAPDH 30 UTR, which lacks an AU-rich region,
does not limit GFP expression (Figure 5A). These results confirm
that the AU-rich region of the IFN-g 30 UTR limits IFN-g produc-
tion in galactose-cultured cells.
Figure 5. GAPDH Associates with the AU-Rich Region of the IFN-g 30 UTR and Regulates IFN-g Production
(A) T cells cultured in glucose (Glc) were transduced with UTR-sensor constructs for 2 days and then recultured in galactose (Gal) for 1 more day before GFP
fluorescence wasmeasured by flow cytometry. The percentage of GFP+ cells is depicted on the top left, and the MFI of those GFP+ events is shown vertically as
indicated.
(B) GAPDH-specific antibodies were used to immunoprecipitate GAPDH from extracts of indicated UTR-sensor construct-transduced T cells cultured in media
with Gal. Associated GFP mRNA bound to GAPDH was analyzed by qRT-PCR. Data show results from one experiment that is normalized to the ARE* mutant
IFN-g 30 UTR construct-transduced cells.
(C) T cells were transfected with Scrambled or GAPDH siRNA. Cells were incubated for 24 hr before analyzing IFN-g by flow cytometry. Shown vertically is theMFI
of the events from IFN-g-producing cells. Data show a representative result from seven independent experiments.
(D) GAPDH expression was determined by qRT-PCR. Relative expression of GAPDH mRNA after Scrambled or GAPDH siRNA transfection is normalized to the
GAPDH expression of Scrambled siRNA samples, p = 0.0049. Bar graph shown as the mean ± SEM (error bar) is generated from data from four independent
experiments.
(E and F) T cells were transduced with GAPDH (GAPDH EX) and empty vector control retrovirus (EV), and intracellular IFN-g (E) and IFN-g secretion by ELISA (F)
were measured after restimulation. Dot plots show IFN-g MFI from CD4+ T cells and are representative of three independent experiments; supernatant was
collected from one experiment (mean ± SEM).
(G) Activated T cells were exposed to varying concentrations of glyceraldehyde 3-phosphate (G3P) in 0.01% saponin on ice for 10 min prior to restimulation.
Data represent similar results from three independent experiments. See also Figure S5.GAPDH Binds the AU-Rich Region of the IFN-g 30 UTR in
Galactose-Cultured CD4 T Cells
The finding that GAPDH binds to the AU-rich region of IFN-g
mRNA in T cells has been previously reported (Nagy and Rigby,
1995), so we sought to establish whether GAPDH protein binds
to the AU-rich region of the IFN-g 30 UTR in our system. There-
fore, we transduced galactose-cultured CD4 Th1 cells with either
the full-length IFN-g 30 UTR or the ARE* mutant constructs,
immunoprecipitated GAPDH, and assessed bound GFP mRNA
transcripts by qRT-PCR. We found that there was 10 times
more GFP mRNA associated with GAPDH in the cells trans-
duced with the full-length IFN-g 30 UTR construct as compared
to those expressing the ARE* mutant (Figure 5B). Together,these results confirm that GAPDH protein binds to the AU-rich
region of the IFN-g promoter in CD4 T cells cultured in galactose.
GAPDH Directly Regulates IFN-g Protein Expression
in CD4 T Cells
To assess whether GAPDH directly regulates IFN-g production,
we used a small interfering RNA (siRNA) approach to decrease
GAPDH expression in CD4 T cells. We found a small but statis-
tically significant increase in IFN-g mean fluorescence intensity
(10% increase, where p = 0.00009 and n = 7) in cells expressing
GAPDH siRNA compared to those expressing scrambled siRNA
(Figure 5C). This result correlates with the modest siRNA-
mediated decrease in gene expression of this highly abundantCell 153, 1239–1251, June 6, 2013 ª2013 Elsevier Inc. 1245
Figure 6. Expression of GAPDH in CD4 T Cells Determines IFN-g Production after Listeria monocytogenes Infection In Vivo
(A–C) A schematic is depicted (A) showing thatmice were infectedwith L. monocytogenes, and splenocyteswere analyzed 7 days later for GAPDH (B) and (C) and
IFN-g (B) and PD-1 (C) expression. Gating for high (GAPDH hi) and low (GAPDH lo) levels of GAPDH expression amongGAPDH-positive cells, or PD-1 expression,
was determined according to isotype controls. The mean fluorescence intensity of IFN-g+ events is shown vertically as indicated. Data (B) and (C) are repre-
sentative of at least two independent experiments.transcript (Figure 5D). To further examine how modulating
GAPDH expression could influence IFN-g production, we
created a retroviral construct to enforce the expression of
GAPDH in activated T cells. We found that retroviral expression
of GAPDH decreased IFN-g production when compared to
T cells transduced with the empty vector (EV) alone (Figures 5E
and 5F). Together, these results indicate that total levels of
GAPDH in activated T cells can influence cytokine production.
To more firmly establish a direct link between GAPDH and
IFN-g production in CD4 T cells and to test our idea that, in addi-
tion to total levels of GAPDH protein, the engagement of GAPDH
in the glycolysis pathway can also influence cytokine production,
we took a different approach and introduced the GAPDH sub-
strate glyceraldehyde 3-phosphate (G3P) into activated T cells
and assessed its influence on cytokine expression. We reasoned
that, because the catalytic site for the enzymatic activity of
GAPDH is the same site where mRNA has been reported to
bind (Nagy et al., 2000), we could essentially force GAPDH to
‘‘engage’’ in the glycolysis pathway by loading T cells with
G3P. We found that galactose-cultured T cells increased IFN-g
production after G3P introduction, whereas glucose-cultured
cells did not (Figure 5G). We speculate that G3P is already avail-
able in T cells cultured in glucose due to endogenous glycolytic
flux. We also found that introduction of G3P promoted the
expression of IL-2 in galactose-cultured cells (Figure S5A).
Taken together, these results support that GAPDH directly regu-
lates IFN-g production in T cells and extend our findings to show
that levels of GAPDH expression, in addition to its preoccupation
in the glycolysis pathway, can influence cytokine production.
It has been previously shown that GAPDH can exist as part of a
complex of proteins that drives transcript selective translation in
myeloid cells (Mukhopadhyay et al., 2009). The formation of this
complex, referred to as the GAIT (gamma interferon (IFN-g)-acti-
vated inhibitor of translation) complex, is induced by IFN-g sig-
nals (Mukhopadhyay et al., 2009). Therefore, we investigated1246 Cell 153, 1239–1251, June 6, 2013 ª2013 Elsevier Inc.whether GAPDH exists as part of the GAIT complex in T cells.
We first assessed whether IFN-g signaling, the regulator of
GAIT, influences IFN-g expression in T cells. Neither culturing
T cells with an exogenous concentration of IFN-g that is known
to induce GAIT in myeloid cells (Arif et al., 2012), nor the addition
of neutralizing antibodies against IFN-g, had any effect on IFN-g
expression by T cells (Figure S5B). We also immunoprecipitated
GAPDH from glucose- and galactose-cultured cells and as-
sessed the binding of other GAIT complex proteins to GAPDH
by western blot. We found no evidence that the GAIT complex
proteins EPRS, NSAP1, or L13a bind to GAPDH to any appre-
ciable extent in these T cells, whether cultured in glucose or
galactose (Figure S5C). Although these observations do not
preclude that GAPDH might exist as part of GAIT in T cells,
they indicate that this is not a major mechanism of how GAPDH
is functioning in our system.
GAPDH Expression Inversely Correlates with IFN-g
Production in CD4 T Cells In Vivo after Infection
To investigate whether the total level of GAPDH can influence
IFN-g production in vivo, we infected mice with Listeria monocy-
togenes and analyzed CD4 T cells 7 days later at the peak of the
effector T cell response (Figure 6A) to this pathogen. We
measured GAPDH expression in CD4 T cells and found that
T cells expressing a higher level of GAPDH produce much less
IFN-g than cells expressing a lower level of GAPDH (Figure 6B),
showing that the level of GAPDH expression determines effector
cytokine production in T cells after infection. Given that PD-1 is a
negative regulator of T cell function and that its expression is
often linked with the inability of T cells to produce optimal levels
of cytokine (termed T cell exhaustion) in many disease states
(Barber et al., 2006), we also assessed the expression of PD-1
on cells with high and low levels of GAPDH. We found that
T cells expressing the highest level of GAPDH, which have the
lowest cytokine production, also have the highest expression
Figure 7. Tumor Cells Impose a Nutrient Restriction on T Cells that Dampens IFN-g Production
(A) T cells were activated with anti-CD3/28 in media containing glucose (Glc) or galactose (Gal), and PD-1 expression was measured.
(B) Activated T cells were cultured in media containing Glc and then differentially cultured in either Glc or Gal (Glc/Gal) for 1 additional day. Cells cultured in Gal
were then recultured in Glc for 1 more day (Glc/Gal/Glc). IFN-g expression was measured 5 days postactivation. Frequencies of IFN-g producing cells are
shown, and plots are representative of three independent experiments.
(C and D) The OCR over ECAR ratio (C) and PD-1 expression (D) of activated T cells cultured in indicated media as described in (B) were assessed.
(E) Activated T cells were cultured in media containing Glc and then differentially cultured in either Glc or Gal for 1 additional day (Glc/Gal (1d)) or 2 days (Glc/
Gal (2d)). Cells cultured in Gal were then recultured in Glc for 1 more day (Glc/Gal/Glc). PD-1 expression was measured 5 days postactivation. Data are
representative of at least two independent experiments (A), (B), and (D), and data are presented as mean ± SEM (error bar) from at least three independent
experiments (C) and (E). *p = 0.0001.
(F and G) (F) T cells were activated with anti-CD3/28 under Th1 polarizing conditions for 3 days. Cells were subsequently incubated overnight with equal numbers
of Th1 cells alone or in a 50/50 mix of EL4 lymphoma cells: Th1 cells. Cells were restimulated (restim) and IFN-g production (F) and glucose concentration in the
media (G) weremeasured. At the time of restimulation, either nothing (no change), 10mMglucose, or newmedia were added back to the cells. Data (F) and (G) are
representative of three independent experiments. Data (G) are presented as mean ± SEM (error bar).
(H) The MFI of PD-1 expression on T cells from the indicated coculture ratios of EL-4 lymphoma cells:Th1 cells are shown.
Data are presented as mean ± SEM (error bar) from one experiment (n = 6). *p = 0.0423; **p = 0.0001. See also Figure S6.of PD-1 when compared to cells expressing low levels of GAPDH
(Figure 6C). These data suggest a link between PD-1 expression
and the engagement of aerobic glycolysis.
Metabolic Phenotype Determines PD-1 Expression
on CD4 T Cells
To further explore the relationship between PD-1 and meta-
bolism, we measured PD-1 expression on CD4 T cells cultured
in glucose and galactose and found that galactose-cultured cells
express higher levels of PD-1 (Figure 7A), which correlated with
their defect in cytokine production. We next assessed whether
cells could regain the ability to produce cytokine after forced
respiration and found that, when cells using aerobic glycolysis
(glucose) are forced to respire (galactose), they develop a defectin IFN-g production that is immediately reversed upon re-
exposure to glucose and engagement of aerobic glycolysis
(Figures 7B and 7C). We also found that, as CD4 T cells were
switched between glucose and galactose, the level of PD-1
expression directly correlated with, and was preceded by,
themetabolic adaptation as dictated by substrate utilization (Fig-
ures 7D and 7E). Together, these results indicate that cellular
metabolism can influence the level of PD-1 expression in CD4
T cells.
Tumor Cells Impose a Reversible Nutrient Restriction
on T Cells that Dampens Cytokine Production
To further substantiate how metabolic adaptions imposed by
nutrient restriction can influence T cell effector function, weCell 153, 1239–1251, June 6, 2013 ª2013 Elsevier Inc. 1247
used a tumor cell:CD4 T cell coculture system. We incubated
overnight equal numbers of Th1 cells alone or in a 50/50 mix of
EL-4 lymphoma cells:Th1 cells, and then after a 4 hr restimula-
tion, wemeasured cytokine production. During the restimulation,
we either added back nothing (no change), 10 mM glucose, or
new media. We found that, as tumor cell density increased,
CD4 T cells reduced IFN-g production to a greater degree than
if cultured with T cells alone (Figure 7F, top row). We found
that this defect in IFN-g production could be rescued simply
by the addition of glucose (Figure 7A, middle row) and even
further enhanced by the addition of new media (Figure 7F, bot-
tom row). Importantly, we confirmed that glucose concentrations
in the media were in fact lower when T cells were cocultured with
tumor cells thanwhen T cells were cultured alone (Figure 7G) and
that media alone contain much higher concentrations of glucose
than either of these conditions (Figure S6).We also found that the
level of PD-1 increased on CD4 T cells as numbers of tumor cells
increased in the coculture (Figure 7H). These results suggest that
lymphoma cells impose a nutrient deprivation on T cells that
limits their ability to produce effector cytokine.
DISCUSSION
The regulation of metabolic pathways in proliferating cells, as
well as how aerobic glycolysis contributes to metabolically regu-
lated signaling mechanisms, remains poorly understood (Loca-
sale and Cantley, 2011; Lunt and Vander Heiden, 2011). We
show that OXPHOS and aerobic glycolysis interchangeably
fuel T cell proliferation and survival, but only aerobic glycolysis
can facilitate full effector status. Specifically, engagement/
disengagement of aerobic glycolysis allows the posttranscrip-
tional regulation of IFN-g production in T cells. We speculate
that the advantage of this regulatory mechanism is that it offers
a metabolic checkpoint for allowing T cell proliferation with or
without accompanying cytokine production. This level of regula-
tion is important because T cells are required to undergo both
homeostatic proliferation, when IFN-g production is neither
required nor desirable, and antigen-driven proliferation during
an immune response, when effector cytokine production is
essential. In this model, the engagement of CD28 by costimula-
tory molecules on pathogen-activated antigen-presenting cells
drives aerobic glycolysis and allows T cells to attain full effector
status (Frauwirth et al., 2002).
Culturing cells with galactose rather than glucose allowed us
to enforce respiration while providing all the known critical
factors for T cell activation and cytokine production—i.e., T cell
receptor ligation, costimulation, and growth factors. By changing
only the sugar substrate provided, we were able to unravel that
aerobic glycolysis is a critical regulator of cytokine production
in T cells. In addition to the regulation of cytokine production,
we also found that PD-1 expression was directly influenced by
the metabolism of the T cells. This finding hints at the intriguing
idea that differing states of T cell exhaustion, which, in many dis-
ease states, is characterized by a loss of effector function and
enhanced PD-1 expression, is fundamentally regulated bymeta-
bolic constraints, rather than chronic antigen stimulation per se
(Barber et al., 2006). It is also worth noting that culturing cells
in galactose where they can use only OXPHOS might model1248 Cell 153, 1239–1251, June 6, 2013 ª2013 Elsevier Inc.physiological conditions in which T cells’ access to or acquisition
of nutrients is altered. This could result from a lack of appropriate
costimulation, a lack of growth factor signals, or direct nutrient
limitations enforced by the presence of other rapidly proliferating
cells, such as might be expected to occur within a tumor micro-
environment; our data showing that, in coculture, tumor cells
impose nutrient restrictions that dampen the ability of T cells to
produce cytokines illustrate this possibility. Although our exper-
iments specifically address the impact of tumor-cell-mediated
glucose deprivation on T cell cytokine production, it is clear
that new complete media can enhance IFN-g production even
further than the addition of glucose alone in our T cell: tumor
cell coculture model. This could be a result of other nutrients in
the media affecting T cell cytokine production. For example, re-
plenishing glutamine in addition to glucose may provide addi-
tional substrates to the T cells and allow a further increase in
cytokine expression. If this were the case, it might suggest that
T cells are severely nutrient impaired, beyond the simple deple-
tion of glucose, in a tumor microenvironment. However, it is also
possible that tumor cells produce inhibitory factors that dampen
T cell cytokine production and that replacing the media removes
or dilutes these factors, allowing T cells to produce cytokines.
This may also apply if there is a buildup of metabolites, or by-
products ofmetabolism, such as lactate, that are able to dampen
cytokine production (Fischer et al., 2007). How these types of
metabolic restrictions might manifest in vivo is currently under
investigation.
Our results show that the glycolysis enzyme GAPDH posttran-
scriptionally regulates T cell effector function by binding to the
AU-rich region in the 30 UTR of cytokine mRNA and reducing
protein translation. Our data indicate that GAPDH-mediated inhi-
bition of effector function in T cells may be controlled at several
levels, such as whether or not the enzyme is occupied by its
metabolic function or by its expression level within cells. It is
also known that the activity of GAPDH is heavily influenced by
the redox state of a cell and that redox-mediated changes can
alter its function and even location within different cellular com-
partments (Colell et al., 2007; Tristan et al., 2011). It is likely that
all of these processes contribute to how GAPDH controls
cytokine expression in vivo. Although GAPDH clearly plays an
important role in cytokine translation in T cells, our study does
not preclude, and may even suggest, the possibility that other
metabolic enzymes control effector cytokine translation or
even other translational programs within cells. This will remain
a focus of further investigation.
Looking beyond any one specific metabolic enzyme, our re-
sults more broadly implicate aerobic glycolysis in general as a
target to control T cell effector functions specifically, rather
than simply controlling the survival and proliferation of respond-
ing T cells. In this light, it is possible that anticancer drugs devel-
oped to inhibit aerobic glycolysis in tumors could be repurposed
to target autoreactive T cells. This approach may allow the inhi-
bition of cytokine production by differentiated effector T cells
without affecting survival, maintenance, or proliferation of the
broader T cell compartment. Furthermore, it is appealing to
speculate that some tumors adopt Warburg metabolism not for
proliferation per se, but for function, and even perhaps for the
optimal expression of factors that facilitate their survival or
modulate the immune response. Regardless of the applications
of these findings, they unexpectedly reveal that a purpose of




C57BL/6 mice were used for all of the experiments. All animals were cared for
according to the Animal Care Guidelines of Washington University School of
Medicine in St. Louis. An attenuated strain of recombinant Listeria monocyto-
genes deleted for actA (LmOVA) was used for immunizations. Mice were
infected intraperitoneally with a sublethal dose of 13 107 colony-forming units
(CFU). Naive (CD44loCD62Lhi) and effector (CD44hiCD62Llo) CD4+ T cells were
isolated and sorted from spleens and lymph nodes.
Cell Cultures
Naive CD4+ T cells were purified by MACS (Miltenyi Biotech) and used in all
experiments. T cells were activated with plate-bound anti-CD3 (5.0 mg/ml)
and soluble anti-CD28 (0.5 mg/ml) antibodies for 3 to 4 days in either nonpola-
rizing (10 U/ml of IL-2) or in T helper type 1 (Th1)-polarizing conditions (10 U/ml
of IL-2, 10 ng/ml of IL-12, and 10 mg/ml anti-IL-4 antibody) as indicated. For
EL4/CD4 cell coculture, activated T cells were cocultured with or without
EL4 cells in varying ratios of cell number as indicated. For cell culture experi-
ments, cells were cultured with RPMI medium (no glucose) containing 10%
dialyzed serum, 1 mM sodium pyruvate, and 2 mM L-glutamine, along with
either 10 mM glucose or 10 mM galactose. For in vitro survival assays, cells
were plated in a 96-well plate in the presence of the indicated inhibitors, and
live cells were assessed daily by 7-AAD exclusion. Cell size/volume were
measured on a Moxi Z cell counter.
Flow Cytometry and Intracellular Cytokine Staining
All antibodies were purchased fromBDPharMingen or eBioscience. To assess
proliferation, cells were fluorescein-labeled with 1 mM CFSE for 8 min at room
temperature. For intracellular cytokine staining, cells were stimulated at 37C
for 4 hr in either glucose or galacose medium supplemented, with or without
indicated inhibitors, in the presence of GolgiStop (BD PharMingen), PMA
(Sigma), and ionomycin (Sigma). For the introduction of glyceraldehyde 3-
phosphate (G3P) into cells, T cells were permeabilized on ice for 10 min with
0.01% saponin in glucose- or galactose-containing media. Cells were then
washed and put in media in the presence of G3P (a 30 min recovery time at
37C before restimulation) for restimulation prior to measuring intracellular cy-
tokines. Representative plots from flow cytometry were all gated on live cells,
either by 7-AAD exclusion or fixable aqua dead cell staining (Invitrogen).
Extracellular Flux Analysis
Oxygen consumption rates (OCR) and extracellular acidification rates (ECAR)
were measured in XF media (nonbuffered RPMI 1640 containing either 10 mM
or 25 mM glucose or galactose, 2 mM L-glutamine, and 1 mM sodium pyru-
vate) under basal conditions and in response to mitochondrial inhibitors,
1 mM oligomycin, and/or 100 nM rotenone + 1 mM antimycin A (Sigma) on
the XF-24 or XF-96 Extracellular Flux Analyzers (Seahorse Bioscience).
RT-PCR and Western Blotting
Total RNA was isolated with the RNeasy kit (QIAGEN), and cDNA was synthe-
sized with the High Capacity cDNA Reverse Transcription Kit (Applied Bio-
systems). All quantitative RT-PCR was performed by the Taqman method,
except for GFP mRNA, which was assayed by the SYBR green method. The
expression of mRNA for genes of interest was normalized to the expression
of b-actin. Cell lysate preparation, SDS–PAGE, electrophoretic transfer, immu-
noblotting, and development were accomplished as previously described
(Pearce et al., 2009). Antibodies for western analysis were purchased from
Cell Signaling. Total protein concentration was determined according to the
BCA method (Thermo Scientific Pierce). Sypro Ruby (Molecular Probes, Inc.)
staining of the gel was performed according to the protocol.Ribosome Analysis
Cells were treated with cycloheximide (Sigma) for 5 min before being
harvested. Equal numbers of cells were lysed, and cytosolic extracts were
separated over 7%–47% sucrose gradients by ultracentrifugation as previ-
ously described (Miceli et al., 2012). Fractions were collected with constant
monitoring of absorbance at 254 nm using a density gradient system
(Teledyne ISCO, Lincoln, NE). RNA was extracted from monosome (40 and
60S), disome (80S), and polysome fractions using RNAsolv (Omega Bio-
Tek) according to the manufacturer’s specifications. Reverse transcription
and qPCR were performed as described above. Numbers of IFN-g and IL-2
transcripts were calculated from a standard curve generated from serial
dilutions of a known quantity of subcloned cDNAs. mRNA distribution was
calculated as a percentage of the total number of transcripts in all collected
fractions.
RNA Immunoprecipitation
Cells were freshly harvested and then crosslinked by treating with 1% formal-
dehyde for 10 min. Cells were resuspended and lysed in polysome lysis buffer.
The lysate was precleared and immunoprecipitated overnight with a rabbit
anti-GAPDH polyclonal antibody (Sigma). Immune complexes were recovered
by Protein A Agarose (Invitrogen), were washed five times with washing
buffers, and were eluted with 1% SDS and 0.1 M NaHCO3. Total lysate and
1% of the eluted fraction were used for western blot analysis. For crosslinking
reversal, the eluted fraction was incubated at 42C for 1 hr, followed by an
additional 2 hr at 65C in the presence of 200 mM NaCl and 20 mg proteinase
K. RNA was then extracted from the eluted fraction using RNAsolv, and mRNA
expression was measured by qPCR as described above.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
six figures and can be found with this article online at http://dx.doi.org/10.
1016/j.cell.2013.05.016.
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